Nemours/AI duPont Hosp-Chld is a clinical research site located in Wilmington, Delaware, United States 19803.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
Nemours/AI duPont Hosp-Chld has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: SGA, Turner Syndrome, Noonan Syndrome, ISS, Sickle Cell Disease, Growth Hormone Disorder.
Sponsors: Novo Nordisk A/S.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Nemours/AI duPont Hosp-Chld has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Nemours/AI duPont Hosp-Chld has 3 clinical trials on record, with 2 currently active. Their work covers SGA, Turner Syndrome, Noonan Syndrome, ISS, Sickle Cell Disease, Growth Hormone Disorder.
Nemours/AI duPont Hosp-Chld has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.